Summary

Dr. Nancy Lin presents the latest advancements in systemic therapies, moderated by Dr. Katarzyna Jerzak. This session explores the evolving landscape of HER2+ brain metastases management and addresses critical challenges in patient care.

Recorded from the LIVE webinar on Apr 9, 2025.

This activity has been funded by an educational grant from AstraZeneca and Daiichi Sankyo and is intended for healthcare practitioners only.

Highlights

  • 1

    Review the current landscape of systemic therapies for HER2+ brain metastases

  • 2

    Explore challenges and opportunities in their management

  • 3

    Provide a Canadian perspective on the clinical impact and treatment approaches

User

Dr. Katarzyna Jerzak, MD, M.Sc., FRCPC

Medical Oncologist, University of Toronto

User

Nancy U. Lin, MD

Associate Chief, Division of Breast Oncology, Dana-Farber Cancer Institute

Comments (0)